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ABSTRACT: T he most common ototoxic compounds in clinical practice are 
a minoglycoside an tibiotics, cispla tin , and loop diuretics (ethacrynic acid a nd 
fu rosemide). T hese agents also have substantial renal effec ts in the form of 
nephrotoxicity or diuresis. T he understanding of these renal effects may provide 
insight int o ototoxic mechanism . For aminoglycos ides, the renal proximal 
tubule cell is susceptible d ue to high concentration achieved and low clearance 
with direct effect on phosphoinositide binding and mitochondrial bioenerget-
ics. Pathogenesis appears to involve iro n-induced free- radical formation, since 
iron chelators p revent nephro toxici ty. Analogo us effec ts of aminoglycosides on 
the inner and out er hair cells have been observed. Cisplatin is also highly con-
centrated in the prox imal tubule cell . Les is known about the direct toxic ef-
fec ts of this agent on renal cell . In ights into mec bani ms on renal tubule cells 
could be direc tly releva nt to the inner ear. T he loop diuretics are direct in-
hibitors of the Na+-K+-2c i- cot ra n port sys tem, which also exists in the margin-
al and dark cells of the stria vasculari s, which a re responsible for endolymph se-
cretion. T he ototoxicity of these agents may be indirect, due to changes in ionic 
composition and nuid volume within the endolymph. 
INTROD CTlON 
A striking association ex ists between the inner ear and the kidney with regards to 
various di ease processes. Three of the most prevalent classes of ototoxic agents, 
which include aminoglycoside ant ibiotics, platinum-containing chemotherapeutic 
agents, and loop diuretics, also have profound toxic or func tional effects on the kid-
ney. In addi tion, a cornn1on genetic di sease, Alport 's syndrome, produces hearing 
loss and renal disea e. Because of this association, insights into the mechanisms of 
toxicity or pharmacologic action of these compounds on the kidney may provide in-
sights into the mechani ms of ototoxicity of these agents. This review summarizes 
the mechanism of action of these drugs on the kidney, and the implications of this ac-
ti on regarding ototox icity. 
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AMINOGLYCOSIDE ANTIBIOTICS 
Aminoglycosides have been clearly shown to have both substantial nephrotox ic 
and ototoxic effects in clinical use. Aminoglycosides are freely filtered by the renal 
glomerules and transported into the proximal tubu le of the kidney. Because the meta-
bolic clearance of aminoglycosides from the tubule cell is slow, th is compound accu-
mulates within these cells. If the dose is substantial and prolonged, toxic concentra-
tions accumulate within the cells, ultimately inducing cell injury, cell necrosis, and 
acute renal failure . 1 The biochemical interactions of the aminoglycosides and renal 
tubule cell components have been well documented, with direct effects on phospho-
inositide metabolism and mitochondrial bioenergetics. Similar find ings regarding 
phospholipid metabo lism have been observed in the inner-ear cells.2 More recent ly, 
an important role for aminoglycos ide-induced free-rad ical generat ion as a patho-
genetic mechanism for renal tubule cell injury has been demonstrated3 Aminoglyco-
sides promote iron mobilization from mitochondria by hydrogen perox ide. In fact, 
scavengers of reactive oxygen metabolites as well as iron chela tors are able to pre-
vent aminoglycoside nephrotoxicity in animal mode ls.4 
The pathophysiology of cochlear and vestibular damage by aminoglycosides has 
been due to the se lective destruction of hair cells, beginning in the cochlea with the 
outer hair cells of the lower tums.5 This pathologic eve nt results in high-frequency 
hearing loss progressing to lower-frequency hearing loss. Unlike the kidney, this oto-
toxicity is not associated with high leve ls of aminoglycosides in inner-ear fluid s, so 
selective toxicity cannot be explained by high penetration and accumulation of these 
antibiot ics within inner-ear tissues.6 Simi lar to the kidney, a role for free radica l-in-
duced damage to the inner ear promoted by these compounds has been demonstrated. 
Protection of aminoglycoside-induced hearing loss has been seen with simultaneous 
administration of iron chelators and free-radical scavengers in anima l experiments. 7 
This effect was not assoc iated with a change in serum leve ls of am inoglycos ides, nor 
with antimicrobia l efficacy. These insights may have important imp lications for the 
prevention of aminoglycoside tox icity in clinical situations. 
CIS-PLATINUM 
cis-Platinum, as with aminoglycos ide antibioti cs, causes nephrotox ic damage to 
renal proximal tubules with resulting renal functi onal impairment. Transport inhibi-
tion of cis-platinum into proximal tubules prevents this tox ic damage. 8 This toxic ef-
fect also appears to relate to the development of iron-induced free-rad ica l generation, 
since iron chelators and free -radical scavenging agents prevent renal damage8 In the 
inner ear, patho logic evaluation demonstrates that cis-platinum promotes degenera-
tive changes in cochlear hair ce lls.9 Hearing loss in treated patients corre lates to cu-
mulative dose, suggesting that tox ic concentrations in inner-ear flu ids or within hair 
ce lls promote these changes. 10· 11 No studies have probed into the biochemical mech-
anisms of cis-plat inum ototox icity, but the similarity observed between other nephro-
toxic and ototoxic actions of various compounds suggests that free radicals are li ke ly 
to be involved. 
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LOOP DIURETICS 
The loop diuretics, including furo semide and ethacrynic acid, are direct inhibitors 
ofthe a+-K ' -2Cl- transport system found along the tubule cells of the loop of Hen-
le in the kidney. 12 This transport inhibition results in a substantial decline in chloride 
transport , with resu lting solute and water diuresis. This transporter has been found 
a long the margi nal and dark cells within the stria vascularis of the inner ear, which 
are responsible for endo lymph secretion. 13 Inhibition of this transport system may re-
late to the ototoxic potential of these compounds due to the resulting changes in the 
ionic composition and fluid vo lume with in the endolymph. Edema within the stria 
vascularis and a decrease in endocochlear potential have been described with the ad-
ministration of these drugs. 14·15 
The toxic or funct ional mechanisms of am inoglycoside antibiotics, cis-platinum, 
and loop diuretics on the kidneys have direct analogies to those seen in the inner ear. 
Because renal tissue and rena l tubu le ce lls are more readily accessible, elucidation of 
the biochemica l and molecu lar mechani sms responsible for nephrotoxicity can pro-
vide insight and potential applicability to the understanding of the ototoxicity of 
these agents. 
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